产品说明书

Eltanexor

Print
Chemical Structure| 1642300-52-4 同义名 : KPT-8602;ONO-7706，ATG-016;eltanexor [INN];Eltanexor [WHO-DD];ELTANEXOR [USAN]
CAS号 : 1642300-52-4
货号 : A579961
分子式 : C17H10F6N6O
纯度 : 99%+
分子量 : 428.291
MDL号 : MFCD30489739
存储条件：

粉末 Keep in dark place,Inert atmosphere,Room temperature

液体 -20°C:3-6个月-80°C:12个月
溶解度 :

DMSO: 105 mg/mL(245.16 mM)，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO
动物实验配方：
生物活性
靶点

  • CRM1
描述 Eltanexor, also known as KPT-8602, is a second-generation, orally administered inhibitor that is highly selective for exportin-1 (XPO1), exhibiting strong anti-leukemic properties. It effectively blocks XPO1-dependent nuclear export with an EC50 of 60.9 nM by directly interacting with XPO1.Eltanexor, administered at concentrations between 2 and 6 nM for a duration of 72 hours, diminishes cell viability in leukemia cell lines, with EC50 values spanning from 25 to 145 nM. Also, it triggers apoptosis in leukemia cell lines[1].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.33mL

0.47mL

0.23mL

11.67mL

2.33mL

1.17mL

23.35mL

4.67mL

2.33mL
参考文献

[1]Vercruysse T et al. The second-generation exportin-1 inhibitor KPT-8602 demonstrates potent activity against acute lymphoblastic leukemia. Clin Cancer Res. 2016 Oct 25.